SBIR PHASE 1 (NIH/NIMH TOPIC 002 - DEVELOPMENT OF NOVEL IN-VITRO AND IN-VIVO MODELS TO SUPPORT NEUROHIV RESEARCH) VALA SCIENCES INC.:1165050 [24-004928]

NIH RePORTER · NIH · N43 · $50,000 · view on reporter.nih.gov ↗

Abstract

This Phase I SBIR contract is in support of Development of novel In-vitro and In-vivo Models to support NeuroHIV Research. hiPSC-NeuroHIV assay, an in vitro model system that mimics certain cellular components of the human brain using cells derived from human induced pluripotent stem cells (hiPSCneurons/ microglia/astrocytes). The hiPSC-NeuroHIV assay system will enable HIV-therapeutics and cART mixtures to be tested for both NeuroHIV effects (neurotoxicity), and for efficacy at blocking HIV replication. has context menu

Key facts

NIH application ID
11222476
Project number
75N95024C00035-0-9999-1
Recipient
VALA SCIENCES, INC.
Principal Investigator
PATRICK M MCDONOUGH
Activity code
N43
Funding institute
NIH
Fiscal year
2024
Award amount
$50,000
Award type
Project period
2024-09-27 → 2025-09-26